NeuroEm Therapeutics said today it launched a clinical trial testing the effect of transcranial electromagnetic treatments on patients with Alzheimer’s disease. The 2-month, phase I clinical trial aims to examine the use of NeuroEm Therapeutics’ electromagnetic technology’s ability to prevent and reverse memory loss related to Alzheimers. Phoenix, Ariz.-based NeuroEm’s TEMT technology uses interdigitated electric and […]